AxoGen, Inc.
NASDAQ:AXGN
Overview | Financials
Company Name | AxoGen, Inc. |
Symbol | AXGN |
Currency | USD |
Price | 15.64 |
Market Cap | 688,289,812 |
Dividend Yield | 0% |
52-week-range | 5.55 - 15.9 |
Industry | Medical Devices |
Sector | Healthcare |
CEO | Ms. Karen Zaderej |
Website | https://www.axogeninc.com |
An error occurred while fetching data.
About AxoGen, Inc.
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector,
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD